We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+34.35%
1 Year Est. Return
-15.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$129M
AUM Growth
+$14.8M
Cap. Flow
-$7.03M
Cap. Flow %
-5.44%
Top 10 Hldgs %
32.12%
Holding
194
New
55
Increased
10
Reduced
22
Closed
72

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$3.66M
2
SEDG icon
SolarEdge
SEDG
+$3.63M
3
STMP
Stamps.com, Inc.
STMP
+$3.57M
4
CTRL
Control4 Corporation
CTRL
+$3.57M
5
OSUR icon
OraSure Technologies
OSUR
+$3.53M

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$5.83M
2
CHGG icon
Chegg
CHGG
+$4.05M
3
SUPN icon
Supernus Pharmaceuticals
SUPN
+$3.85M
4
W icon
Wayfair
W
+$3.84M
5
MDXG icon
MiMedx Group
MDXG
+$3.69M

Sector Composition

Rank Sector Weight
1 Technology 27.65%
2 Consumer Discretionary 20.05%
3 Healthcare 19.63%
4 Consumer Staples 9.11%
5 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
126
Bank of America
BAC
$428B
– –
-195
Closed -$5K
BG icon
127
Bunge Global
BG
$21.4B
– –
-100
Closed -$7K
BKH icon
128
Black Hills Corp
BKH
$5.6B
– –
-108
Closed -$7K
BLD
129
DELISTED
TopBuild
BLD
– –
-140
Closed -$7K
BLUE
130
DELISTED
bluebird bio
BLUE
– –
-2,234
Closed -$3.04M
CCJ icon
131
Cameco
CCJ
$46.3B
– –
-200
Closed -$2K
EVRI
132
DELISTED
Everi Holdings
EVRI
– –
-1,048
Closed -$8K
EXEL icon
133
Exelixis
EXEL
$13.7B
– –
-209
Closed -$5K
FIVN icon
134
FIVE9
FIVN
$2.58B
– –
-305
Closed -$7K
GDOT icon
135
Green Dot
GDOT
$762M
– –
-188
Closed -$7K
ICHR icon
136
Ichor Holdings
ICHR
$2.21B
– –
-266
Closed -$5K
IHI icon
137
iShares US Medical Devices ETF
IHI
$3.37B
– –
-108
Closed -$3K
IRBT
138
DELISTED
iRobot
IRBT
– –
-36,074
Closed -$3.04M
IWO icon
139
iShares Russell 2000 Growth ETF
IWO
$15.1B
– –
-8
Closed -$1K
IYJ icon
140
iShares US Industrials ETF
IYJ
$1.91B
– –
-46
Closed -$3K
KBH icon
141
KB Home
KBH
$3.35B
– –
-350
Closed -$8K
KLIC icon
142
Kulicke & Soffa
KLIC
$4.43B
– –
-331
Closed -$6K
KNSL icon
143
Kinsale Capital Group
KNSL
$8.7B
– –
-207
Closed -$8K
LNTH icon
144
Lantheus
LNTH
$6.56B
– –
-455
Closed -$8K
LRCX icon
145
Lam Research
LRCX
$399B
– –
-218,480
Closed -$3.09M
MDXG icon
146
MiMedx Group
MDXG
$657M
– –
-246,269
Closed -$3.69M
MELI icon
147
Mercado Libre
MELI
$97.9B
– –
-12,581
Closed -$3.16M
MMSI icon
148
Merit Medical Systems
MMSI
$5.35B
– –
-208
Closed -$8K
MOS icon
149
The Mosaic Company
MOS
$7.55B
– –
-200
Closed -$5K
NFLX icon
150
Netflix
NFLX
$332B
– –
-216,450
Closed -$3.23M
4 5
6
7 8

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
DFAM
Deep Field Asset Management Beverly Hills, California $57.7M AUM 29.92% 1-Year Est. Return
AI
Abanco Investors Middletown, Rhode Island $57.9M AUM
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return

Crosspoint Capital Strategies's Q3 2017 Portfolio in Review

As of Q3 2017, Crosspoint Capital Strategies held 194 positions worth $129M, up 13% from $114M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Crosspoint Capital Strategies withdrew a net $7.03M in Q3 2017, closing 72 positions and reducing 22 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $5.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Crosspoint Capital Strategies opened a new position in Boeing worth $3.99M.

  • Crosspoint Capital Strategies's largest Q3 2017 buy was Boeing: 15,706 shares worth $3.99M.
  • Crosspoint Capital Strategies added most to Control4 Corporation in Q3 2017, an estimated $3.57M increase.
  • Crosspoint Capital Strategies's biggest Q3 2017 reduction was Chegg, cutting an estimated $4.05M.
  • Crosspoint Capital Strategies fully exited Clovis Oncology, Inc. in Q3 2017, selling an estimated $5.83M.
  • Crosspoint Capital Strategies's ten largest holdings make up 32% of its $129M portfolio in Q3 2017.
  • Crosspoint Capital Strategies opened 55 new positions and closed 72 in Q3 2017.
  • Crosspoint Capital Strategies's portfolio value rose 13% quarter-over-quarter to $129M.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2017, filed 6 Nov 2017.